1-Pentanol

1-Pentanol

SCHEMBL1996339

CC#N.CCCCCO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1-Pentanol SCHEMBL27663694 1.00 SMN1; SMN2 (0.71)
1-Hexanol SCHEMBL15874705 0.97 LMNA (0.72)
1-Heptanol SCHEMBL28112955 0.97 LMNA (0.72)
Octanol SCHEMBL28798465 0.95 ALDH1A1 (0.68)
Butyl Alcohol SCHEMBL601846 0.91
Butyl Alcohol SCHEMBL7422679 0.91
Decanol SCHEMBL28044745 0.88 LMNA (0.77)
Hexane SCHEMBL7503624 0.88 SMN1; SMN2 (0.50)
1-Pentanol SCHEMBL30726635 0.87
1-Pentanol SCHEMBL5551459 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116500156-A Separation and detection method for perindopril tert-butylamine stereoisomer impurity 上海市食品药品检验研究院 2023-07-28 CN claimed
CN-116500156-A Separation and detection method for perindopril tert-butylamine stereoisomer impurity 上海市食品药品检验研究院 2023-07-28 CN disclosed
CN-116500156-A Separation and detection method for perindopril tert-butylamine stereoisomer impurity 上海市食品药品检验研究院 2023-07-28 CN disclosed
US-20120328518-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN INHIBITORS PIRAMAL IMAGING SA (CH) 2012-12-27 US disclosed
EP-2513121-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN INHIBITORS Piramal Imaging SA (CH) 2012-10-24 EP disclosed
EP-2338892-A1 Prostate specific membrane antigen inhibitors Bayer Schering Pharma Aktiengesellschaft (DE) 2011-06-29 EP disclosed
WO-2011073286-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-06-23 WO disclosed